A Phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium

Project: Research project

Project Details

Description

A Phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium
StatusActive
Effective start/end date10/31/18 → 10/31/23

Funding

  • UNIV. OF OKLAHOMA HEALTH SCIENCES CENTER
View all
View less